Skip to search formSkip to main contentSkip to account menu

WY 45727

Known as: WY-45,727 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1989
1989
1. The effects of single daily doses of 20, 50 and 150 mg of WY-45,727, a novel H2-receptor antagonist, and placebo were compared… 
1988
1988
The most common treatment for gastric and duodenal ulcers is by suppressing the secretion of gastric acid by the parietal cells…